ArticleAmerican journal of respiratory and critical care medicine2023
Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
Abstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 53 citations in OpenAlex.
- Telomere-associated non-malignant pulmonary diseases: Pathogenic mechanisms and therapeutic strategies.Acta pharmaceutica Sinica. B · 2026Review
- Endothelial GDF15 deficiency enhances barrier function and mitigates pulmonary fibrosis.JCI insight · 2026Article
- ERS Congress 2025: highlights from the Pulmonary Vascular Diseases Assembly.ERJ open research · 2026Article
- Emergency donor pericardial conduit for ruptured pulmonary artery in lung transplantation for severe PH: a case report.Journal of cardiothoracic surgery · 2026Article
- Inactivation Rap2a in Endothelial Cell Prevents Pulmonary Fibrosis by Regulating Immune Microenvironment Through MAP4K4-VCAM1 Signaling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Far Infrared Radiation Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Modulation of the p53/TGF-β Signaling Pathway.International journal of molecular sciences · 2026Article
- Single cell spatial transcriptomics integration deciphers the morphological heterogeneity of atherosclerotic carotid arteries.Nature communications · 2025Article
- β-III tubulin identifies anti-fibrotic state of pericytes in pulmonary fibrosis.Research square · 2025Article
- Fibrosis: cross-organ biology and pathways to development of innovative drugs.Nature reviews. Drug discovery · 2025Review
- Transcriptional signatures of endothelial cells shape immune responses in cardiopulmonary health and disease.JCI insight · 2025Review
- From Epithelium to Therapy: Transitional Cells in Lung Fibrosis.American journal of respiratory cell and molecular biology · 2025Review
- Observational
- Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis.BMC medicine · 2025Article
- Identifying Mechanism of Resveratrol for the Treatment of COVID-19 and Idiopathic Pulmonary FibrosisCurrent medicinal chemistry · 2025Article
- New perspectives on the progression of pulmonary fibrosis: the cascade from aberrant microvascular endothelial cell activation to fibrosis.Frontiers in medicine · 2025Review
- Identification of PANoptosis-related genes for idiopathic pulmonary fibrosis by machine learning and molecular subtype analysis.Scientific reports · 2024Article
- Dissecting the lung transcriptome of pulmonary fibrosis-associated pulmonary hypertension.American journal of physiology. Lung cellular and molecular physiology · 2024Article
- Molecular Interplay in Cardiac Fibrosis: Exploring the Functions of RUNX2, BMP2, and Notch.Reviews in cardiovascular medicine · 2024Review
- Review
- Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease.Life (Basel, Switzerland) · 2024Review
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
21 authors at 8 institutions in 6 countries.
Toyoshi YanagiharaFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.ORCID 0000-0002-2212-0631
Kazuya TsubouchiFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.
Quan ZhouFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.
Michael ChongGenetic and Molecular Epidemiology Laboratory, Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Thrombosis and Atherosclerosis Research Institute, Department of Biochemistry and Biomedical Sciences.
Kohei OtsuboFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.
Takuma IsshikiFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.
Jonas C SchuppSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut.ORCID 0000-0002-7714-8076
Seidai SatoFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.
Ciaran ScallanFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.ORCID 0000-0001-7892-9336
Chandak UpaguptaFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.
Spencer RevillFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.
Anmar AyoubFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.
Sy Giin ChongFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.
Anna Dvorkin-GhevaMcMaster Immunology Research Centre, Department of Medicine.
Naftali KaminskiSection of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut.ORCID 0000-0001-5917-4601
Jussi TikkanenToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Shaf KeshavjeeToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.ORCID 0000-0003-4547-8094
Guillaume ParéDepartment of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, and.
Christophe GuignabertINSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, France.
Kjetil AskFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.ORCID 0000-0002-0202-735X
Martin R J KolbFirestone Institute for Respiratory Health, Research Institute at St. Joseph's Healthcare, and.ORCID 0000-0003-3837-1467
Institute for Respiratory Health · AUKyushu University · JPToho University · JPUniversity Health Network · CAYale University · USInserm · FRMcMaster University Medical Centre · CAPopulation Health Research Institute · CA
Funding
CIHR PJT-162295
Abstract
PubMed holds no abstract for this paper.
Indexed as
Hypertension, PulmonaryIdiopathic Pulmonary FibrosisAnimalsBone Morphogenetic Protein Receptors, Type IIEndothelial CellsFibroblastsHumansLungRatsTacrolimusTransforming Growth Factor beta1Vascular RemodelingBMPR2 protein, humanBmpr2 protein, ratBone Morphogenetic Protein Receptors, Type IITacrolimusTransforming Growth Factor beta1BMPR2idiopathic pulmonary fibrosispulmonary hypertensiontacrolimusvascular remodeling
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.